SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NKTR Drug delivery Company
NKTR 55.97+1.5%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (417)10/1/2018 6:06:45 PM
From: Miljenko Zuanic  Read Replies (1) of 507
 
O4Immune monitoring after NKTR-214 plus nivolumab (PIVOT-02) in previously untreated patients with metastatic Stage IV melanomaAdi Diab1; Scott Tykodi; Brendan D. Curti2; Daniel C. Cho3; Michael K. Wong; Igor Puzanov4; Karl D. Lewis5; Michele Maio6; Gregory A. Daniels7; Alexander I. Spira8; Mary A. Tagliaferri9; Michael Imperiale; Alison L. Hannah; Wendy Clemens; Chantale Bernatchez; Jonathan Zalevsky10; Ute Hoch11; Christie Fanton12; Ahsan N. Rizwan13; Sandra Aung14; Fiore Cattaruzza; Ernesto Iaccucci; Dariusz Sawka; Mehmet A. Bilen15; Paul Lorigan; Giovanni Grignani; James Larkin16; Sekwon Jang17; Ewa Kalinka-Warzocha18; Mario Sznol19; Michael E. Hurwitz20; Adi Diab21; Salah Eddine Bentebibel; Cara Haymaker221University of Texas MD Anderson Cancer C; 2Earle A. Chiles Research Institute, Prov; 3NYU Medical Oncology Associates; 4Roswell Park Comprehensive Cancer Center; 5University of Colorado; 6University Hospital of Siena; 7University of California San Diego Moore; 8Virginia Cancer Specialists Research Institute; 9Nektar Therapeutics; 10Nektar Therapeutics; 11Nektar; 12Nektar Therapeutics; 13Nektar Therapeutics; 14Nektar Therapeutics; 15Winship Cancer Institute of Emory Univer; 16Royal Marsden Hospital; 17Inova Schar Cancer Institute; 18Polish Mothers Memorial Hospital; 19Yale Cancer Center; 20Yale Cancer Center; 21University of Texas MD Anderson Cancer C; 22University of Texas MD Anderson Cancer Center
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News